Position in LLY
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$231,490
+$53,975 QoQ
Shares Held
193
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#4,345
of 4,605 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kennebec Savings Bank holds $7,180,098 across 9 Drug Manufacturers - General names. LLY ranks #5 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
9,247 | $2,326,915 | |
| 2 | MRK |
Merck & Co., Inc.
|
16,803 | $2,159,185 | |
| 3 | JNJ |
Johnson & Johnson
|
5,867 | $1,490,041 | |
| 4 | NVS |
Novartis AG
|
5,163 | $809,145 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
193 | $231,490 | |
| 6 | PFE |
Pfizer Inc
|
2,600 | $62,608 | |
| 7 | AMGN |
Amgen Inc
|
126 | $45,627 | |
| 8 | NVO |
Novo Nordisk A S
|
892 | $42,762 |
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $231,490 | 193 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $177,515 | 193 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $207,413 | 193 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $147,259 | 193 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $150,449 | 193 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $165,182 | 200 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $154,400 | 200 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $194,020 | 219 | Shares | Sole | 2024-11-04 | |
| No filing history on record for this holder in this stock. | ||||||